Blocking macrophage phagocytosis has resulted in improved tumor control over a range of targets and tumor models57,64–69, and our data suggests that Enpp1 inhibition may be a general strategy to improve tumor immunogenicity and radioimmunogenicity70. This evidence concerns the gene ENPP1 and neoplasm.